BIOLASE, INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biolase, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Biolase, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$695K, a 81.2% increase year-over-year.
  • Biolase, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$13.5M, a 36.5% increase year-over-year.
  • Biolase, Inc annual Operating Income (Loss) for 2023 was -$17.9M, a 29.2% increase from 2022.
  • Biolase, Inc annual Operating Income (Loss) for 2022 was -$25.3M, a 54.2% decline from 2021.
  • Biolase, Inc annual Operating Income (Loss) for 2021 was -$16.4M, a 11.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$13.5M -$695K +$3M +81.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$16.5M -$3.22M +$652K +16.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$17.2M -$4.53M +$765K +14.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$17.9M -$5.08M +$3.35M +39.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$21.3M -$3.7M +$3.95M +51.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$25.2M -$3.87M +$1.18M +23.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$26.4M -$5.29M -$1.09M -25.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$25.3M -$8.43M -$4M -90.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$21.3M -$7.65M -$4.99M -188% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$16.3M -$5.06M -$1.77M -54% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$14.6M -$4.21M +$1.86M +30.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$16.4M -$4.43M +$1.11M +20% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-21
Q3 2021 -$17.5M -$2.66M +$1.01M +27.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$18.6M -$3.28M +$696K +17.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$19.2M -$6.06M -$710K -13.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$18.5M -$5.54M -$2.5M -82.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 -$16M -$3.67M +$1.22M +24.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$17.3M -$3.98M -$642K -19.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$16.6M -$5.35M -$988K -22.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$15.6M -$3.04M +$3.47M +53.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 -$19.1M -$4.88M -$372K -8.25% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$18.7M -$3.34M +$1.34M +28.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$20.1M -$4.36M +$820K +15.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$20.9M -$6.51M -$1.79M -37.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-31
Q3 2018 -$19.1M -$4.51M +$251K +5.27% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$19.3M -$4.68M -$199K -4.44% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$19.1M -$5.18M -$1.11M -27.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$18M -$4.72M -$607K -14.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 -$17.4M -$4.76M -$1.61M -51.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$15.8M -$4.48M -$1.09M -32.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$14.7M -$4.08M +$237K +5.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$15M -$4.11M -$1.84M -80.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 -$13.1M -$3.15M +$2.2M +41.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$15.3M -$3.39M +$3.64M +51.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$19M -$4.31M +$946K +18% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$19.9M -$2.28M +$1.54M +40.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$21.5M -$5.35M -$2.06M -62.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$19.4M -$7.03M -$837K -13.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 -$18.6M -$5.26M -$624K -13.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$17.9M -$3.82M -$1.79M -88.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$16.1M -$3.3M +$566K +14.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$16.7M -$6.19M -$3.9M -170% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$12.8M -$4.64M -$1.82M -64.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 -$11M -$2.03M -$3.22M -270% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$7.78M -$3.86M -$3.47M -895% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$4.31M -$2.29M -$579K -33.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$3.73M -$2.82M -$1.2M -73.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$2.53M $1.19M +$3.14M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 -$5.67M -$388K +$550K +58.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$6.22M -$1.71M -$996K -139% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$5.22M -$1.62M -$1.22M -300% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$4M -$1.94M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$938K +$1.49M +61.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$717K +$3.41M +82.6% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-06
Q1 2011 -$406K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$2.42M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$4.12M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.